ALISON LENZ: Open Payments
NPI 1114203379 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 13 payments from 10 companies in 2025. Trend: 2023 $766 · 2024 $565 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $114 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ABBVIE INC. | 2 | $40 |
| Gilead Sciences, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Exact Sciences Corporation | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: BREZTRI, REXULTI, VRAYLAR, CAPLYTA, Cologuard Collection Kit, Fluad, MOUNJARO, GARDASIL 9.
Industry payments across CO — which companies pay providers there.
